Suppr超能文献

相似文献

1
The symptomatic management of multiple sclerosis.
Ann Indian Acad Neurol. 2009 Oct;12(4):291-5. doi: 10.4103/0972-2327.58278.
2
Symptom management in patients with multiple sclerosis.
J Neurol Sci. 2011 Dec;311 Suppl 1:S48-52. doi: 10.1016/S0022-510X(11)70009-0.
3
Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions.
Lancet Neurol. 2010 Dec;9(12):1182-1199. doi: 10.1016/S1474-4422(10)70249-0.
4
Need for symptomatic management in advanced multiple sclerosis.
Acta Neurol Scand. 2017 May;135(5):529-532. doi: 10.1111/ane.12631. Epub 2016 Jun 29.
5
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.
7
Symptom Management Among Multiple Sclerosis Care Partners in Canada.
Int J MS Care. 2023 Nov-Dec;25(6):281-287. doi: 10.7224/1537-2073.2022-113. Epub 2023 Nov 8.
8
Symptomatic therapy of multiple sclerosis.
Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):90-104. doi: 10.1212/01.CON.0000389936.61789.04.
9
Clinical Practice Guideline: Nosebleed (Epistaxis).
Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.

引用本文的文献

1
Surveying sleep quality and fatigue in multiple sclerosis patients at a multiple sclerosis center in Kermanshah, Iran, in 2017.
Neurobiol Sleep Circadian Rhythms. 2020 May 11;8:100050. doi: 10.1016/j.nbscr.2020.100050. eCollection 2020 May.
3
A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol.
F1000Res. 2015 Sep 18;4:872. doi: 10.12688/f1000research.7040.1. eCollection 2015.
4
Disease-modifying therapies in relapsing-remitting multiple sclerosis.
Neuropsychiatr Dis Treat. 2010 Sep 7;6:365-73. doi: 10.2147/ndt.s11079.

本文引用的文献

1
Improved bladder emptying in urinary retention by electrical stimulation of pudendal afferents.
J Neural Eng. 2008 Jun;5(2):144-54. doi: 10.1088/1741-2560/5/2/005. Epub 2008 Apr 22.
2
Treatment strategies for diabetic patients suffering from erectile dysfunction.
Expert Opin Pharmacother. 2008 Feb;9(2):257-66. doi: 10.1517/14656566.9.2.257.
3
Pharmacological treatment of pain in multiple sclerosis.
Expert Rev Neurother. 2007 Sep;7(9):1165-74. doi: 10.1586/14737175.7.9.1165.
4
The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.
Expert Opin Drug Saf. 2007 May;6(3):279-88. doi: 10.1517/14740338.6.3.279.
7
EFNS guidelines on pharmacological treatment of neuropathic pain.
Eur J Neurol. 2006 Nov;13(11):1153-69. doi: 10.1111/j.1468-1331.2006.01511.x.
8
Intrathecal baclofen therapy: challenges in patients with multiple sclerosis.
Rehabil Nurs. 2006 Jul-Aug;31(4):158-64. doi: 10.1002/j.2048-7940.2006.tb00381.x.
9
Cognition in the early stage of multiple sclerosis.
J Neurol. 2006 Aug;253(8):1002-10. doi: 10.1007/s00415-006-0145-8. Epub 2006 Apr 11.
10
Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
Drug Saf. 2006;29(1):31-48. doi: 10.2165/00002018-200629010-00003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验